InvestorsHub Logo
Followers 453
Posts 26720
Boards Moderated 1
Alias Born 09/11/2006

Re: None

Tuesday, 01/22/2013 8:44:21 AM

Tuesday, January 22, 2013 8:44:21 AM

Post# of 18
12:51AM Theratechnologies: FDA approves alternative storage conditions for EGRIFTA (THER) 0.39 : Co announces the FDA has granted approval of a Supplemental New Drug Application (sNDA), filed by its commercial partner, EMD Serono, providing for the revision of the EGRIFTA prescribing information, to include storage conditions for the 2 mg vial up to 12 weeks at or below 25 degrees C after dispensing to the patient. Previously, EGRIFTA(TM) could only be stored between 2 degrees C and 8 degrees C (36 degrees F and 46 degrees F) until the expiration date.